> JOURNAL ARTICLES > Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
Share it on
Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
TITLE OF PUBLICATION March 01, 2013
Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
AUTHORS
Sanfélix-Genovés J, Sanfélix-Gimeno G, Peiró S, Hurtado I, Fluixà C, Fuertes A, Campos JC, Giner V, Baixauli C.
Abstract
This study provides information on the prevalence of the most
important risk factors for osteoporosis and osteoporotic fracture
in a large sample of women and men from the Valencia region and
also provides the FRAX 10-year major and hip fracture risks for
this population, as well as data about the use of diagnostic tests
and antiosteoporotic treatments.
INTRODUCTION:
The purpose of this study was to describe demographic
characteristics, osteoporosis risk factors, the 10-year risk of
osteoporotic fracture, and the use of densitometry and
antiosteoporotic treatments in the Valencia region, Spain.
METHODS:
A cross-sectional study using the ESOSVAL cohort baseline
data was conducted. We analyze the data from 5,310 women and 5,725
men aged 50 and over who attended to 272 collaborating primary care
centers in 2009-2010. We collected the demographic, anthropometric,
clinical, and pharmacy data from the electronic medical record.
RESULTS:
The mean age of participants was 64.3 years old for women
and 65.6 years old for men. The most frequent fracture risk factors
were sedentary life (22.2 %) and previous fracture (15.8 %) in
women and low calcium intake (21.4 %) and current smoker (20.9 %)
in men. According to FRAX(®), the 10-year risk of presenting a
major fracture was 5.5 % for the women and 2.8 % for the men. The
10-year risk for hip fracture was 1.9 and 1.1 % for the women and
the men, respectively; 23.8 % of the women and 5.2 % of the men had
a densitometry test, 27.7 % of the women and 3.5 % of the men were
taking calcium and/or vitamin D supplements, and 28.2 % of the
women (22.0 % in the 50-64 age group) and 2.3 % of the men were
taking antiosteoporotic drugs.
CONCLUSIONS:
The prevalence of certain fracture risk factors not included
in the FRAX tool (sedentary life, falls, low calcium intake) is
high. In young women, their low risks estimated by FRAX contrast
with the high figures for densitometry testing and treatment.
